Literature DB >> 2417414

Identification of antigenic determinants by polyclonal and hybridoma antibodies induced during the course of infection by vaccinia virus.

S Wilton, J Gordon, S Dales.   

Abstract

In order to extend the understanding of determinants involved in the humoral response in the infected host, mice were subjected to an immunization regimen using both active and uv-killed vaccinia virus. The spectrum of antibody specificity in hyperimmune sera was followed by Western blotting. Comparable studies involving Western blotting and immunofluorescence were conducted with a panel of monoclonal antibodies derived from hybridomas selected from similarly immunized animals. Hyperimmune sera contained circulating antibodies primarily against three polypeptides of 28K, 35K, and 62K. These antigens were shown to be located both at the surface and within the virion. The repertoire of monoclonal antibodies included some that reacted with the 28K and 35K antigens and others that recognized a 32K core complex component or a nonvirion cell surface component, corresponding to the viral hemagglutinin. Within the panel of monoclonal antibodies was a large group which reacted with a 32K antigen found in the IHD-J virion but absent from the IHD-W strain. This finding correlates with the absence of a 32K polypeptide from the IHD-W particle. Overall, the current findings reveal the absence of any particular correlation between the incidence of polyclonal antibodies in the circulation of the immune host and the frequency of selected hybridomas against vaccinia antigens. Application of this type of immunological analysis should provide useful data concerning the detection and mapping of the antigens and their epitopes which are significant for humoral immunity.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2417414     DOI: 10.1016/0042-6822(86)90405-8

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  14 in total

1.  Vaccinia virus envelope H3L protein binds to cell surface heparan sulfate and is important for intracellular mature virion morphogenesis and virus infection in vitro and in vivo.

Authors:  C L Lin; C S Chung; H G Heine; W Chang
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

2.  Identification and characterization of vaccinia virus genes encoding proteins that are highly antigenic in animals and are immunodominant in vaccinated humans.

Authors:  W E Demkowicz; J S Maa; M Esteban
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

3.  Identification of viral antigenic determinants by monoclonal antibodies directed against Chilo iridescent virus (iridovirus type 6). Brief report.

Authors:  N Orange; J Guerillon; G Devauchelle
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

4.  Generation and characterization of a large panel of murine monoclonal antibodies against vaccinia virus.

Authors:  Xiangzhi Meng; Youmin Zhong; Addie Embry; Bo Yan; Shan Lu; Guangming Zhong; Yan Xiang
Journal:  Virology       Date:  2010-11-05       Impact factor: 3.616

5.  Structural and functional studies of a 39,000-Mr immunodominant protein of vaccinia virus.

Authors:  J S Maa; M Esteban
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

6.  Vaccinia virus H3L envelope protein is a major target of neutralizing antibodies in humans and elicits protection against lethal challenge in mice.

Authors:  D Huw Davies; Megan M McCausland; Conrad Valdez; Devan Huynh; Jenny E Hernandez; Yunxiang Mu; Siddiqua Hirst; Luis Villarreal; Philip L Felgner; Shane Crotty
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

7.  Immunotherapy of the rat 13762SC mammary adenocarcinoma by vaccinia virus augmentation of tumor immunity.

Authors:  T P Archer; P Bretscher; B Ziola
Journal:  Clin Exp Metastasis       Date:  1990 Nov-Dec       Impact factor: 5.150

8.  Vaccinia virus gene H5R encodes a protein that is phosphorylated by the multisubstrate vaccinia virus B1R protein kinase.

Authors:  G Beaud; R Beaud; D P Leader
Journal:  J Virol       Date:  1995-03       Impact factor: 5.103

9.  Relationship between RNA polymerase II and efficiency of vaccinia virus replication.

Authors:  S Wilton; S Dales
Journal:  J Virol       Date:  1989-04       Impact factor: 5.103

10.  The immune response to vaccinia virus infection in mice: analysis of the role of antibody.

Authors:  F J Novembre; K Raska; J A Holowczak
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.